论文部分内容阅读
目的:探讨深部热疗联合参芪扶正注射液治疗恶性胸腔积液患者的疗效。方法:选取2013年1月-2015年12月广州中医药大学附属新会中医院66例恶性胸腔积液患者,随机分为两组,每组33例。对照组给予洛铂胸腔灌注,治疗组在对照组的基础上给予深部热疗联合参芪扶正注射液静脉注射,比较两组患者的临床疗效及生活质量改善情况。结果:两组的疗效比较,治疗组的总有效率为81.8%,明显高于对照组的60.6%,差异具有统计学意义(P<0.05);两组Karnofsky评分比较是治疗组的总有效率为84.8%,显著高于对照组的60.6%(P<0.01)。结论:深部热疗联合参芪扶正注射液治疗恶性胸腔积液有较好的疗效,能提高患者的生存质量。
Objective: To investigate the effect of deep hyperthermia combined with Shenqi Fuzheng injection in patients with malignant pleural effusion. Methods: Sixty-six patients with malignant pleural effusion from January 2013 to December 2015 in Xinhui Chinese Medicine Hospital of Guangzhou University of Chinese Medicine were randomly divided into two groups (n = 33 in each group). The control group received lobaplatin pleural perfusion. The treatment group received deep hyperthermia combined with Shenqi Fuzheng injection on the basis of the control group. The clinical efficacy and quality of life of the two groups were compared. Results: The total effective rate of the two groups was 81.8%, which was significantly higher than that of the control group (60.6%), the difference was statistically significant (P <0.05); the Karnofsky score of the two groups was the total effective rate Was 84.8%, significantly higher than 60.6% of the control group (P <0.01). Conclusion: Deep hyperthermia combined with Shenqi Fuzheng injection in the treatment of malignant pleural effusion has a good curative effect, which can improve the quality of life of patients.